Gene-editing therapies—techniques that modify DNA to treat or prevent disease—have the potential to transform the field of ...
UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...
CRISPR genome editing is revolutionizing medicine. Rapid market growth, fueled by startups and new therapies, brings ethical ...
CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: ...
HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines, today announced the appointment of Dr. TJ Cradick as Chief ...
Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...
News Medical on MSN5d
Gene editing approach helps launch first-in-human clinical trial for rare genetic diseaseA collaborative effort between investigators at the National Institutes of Health's National Institute of Allergy and ...
CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...
Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...
Discover how genetic mutations, like BRCA1 and BRCA2, impact cancer risk and personalized treatment strategies.
Researchers in biomedical engineering will use the NIH award to conduct an in-depth analysis of the genetic and cellular determinants of gene therapy longevity.
Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback